Treatment and Management of Scleral Disorders

Abstract Scleral inflammatory disorders, with their extensive differential diagnoses and sometimes as controversial treatment options, pose both diagnostic and clinical challenges for physicians. Targeted laboratory investigations derived from careful history taking and physical examination are cruc...

Full description

Saved in:
Bibliographic Details
Published inSurvey of ophthalmology Vol. 61; no. 6; pp. 702 - 717
Main Authors Diaz, Jose D., MD, Sobol, Ethan K., BA, Gritz, David C., MD, MPH
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Scleral inflammatory disorders, with their extensive differential diagnoses and sometimes as controversial treatment options, pose both diagnostic and clinical challenges for physicians. Targeted laboratory investigations derived from careful history taking and physical examination are crucial in the early identification of patients with associated systemic conditions. Prompt discrimination between episcleritis and scleritis is of therapeutic importance, as management, prognosis, and complications differ for these diseases. Although immunomodulatory and new biologic agents have improved the management of scleritis, continued studies are warranted in order to establish effective treatment guidelines across patient populations, especially in refractory cases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0039-6257
1879-3304
DOI:10.1016/j.survophthal.2016.06.002